Streetbeat News

AMT

American Tower Corporation

https://www.americantower.com

Industry

REIT - Specialty

American Tower Corporation, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 219,000 communications sites. For more information about American Tower, please visit the "Earnings Materials" and "Investor Presentations" sections of our investor relations website at www.americantower.com.

Open

195.00

Mkt cap

92B

Volume

2.6M

High

196.73

P/E Ratio

47.34

52-wk high

243.56

Low

193.75

Div yield

0.03

52-wk low

170.46

Scotiabank analyst Maher Yaghi maintains a Sector Outperform rating on American Tower (NYSE:AMT) but lowers the price target from $248 to $236.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 7:12 pm

BMO Capital has maintained an Outperform rating on American Tower (NYSE:AMT) but has lowered the price target from $255 to $245.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 2:12 pm

American Tower's shares declined following disappointing Q3 financial results and a reduction in FY24 AFFO guidance.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 2:02 pm

American Tower has revised its FY24 AFFO guidance downwards, with new estimates ranging from $10.45 to $10.62 per share, compared to the previous range of $10.48 to $10.72. The company also projects total property revenue between $9.89 billion and $9.98 billion.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 11:07 am

American Tower's Q3 2024 earnings and sales missed analyst estimates. Earnings per share were $2.52, below the $2.58 estimate, and sales were $2.52 billion, missing the $2.76 billion estimate. Despite the miss, earnings per share increased by 2.86% from last year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 11:03 am

Jim Cramer discussed several stocks on CNBC's 'Mad Money Lightning Round.' He sees value in CVS Health, praises Micron Technology's quarter, and recommends buying Robinhood and Modine Manufacturing. He advises against American Tower and considers ADMA Biologics speculative.

Portfolio Pulse from Avi Kapoor

October 11, 2024 | 1:06 pm

Top Wall Street analysts have downgraded several major stocks, including Skyworks Solutions, American Tower, Honeywell, PayPal, and Huntington Ingalls. These downgrades reflect changes in analyst sentiment and price targets.

Portfolio Pulse from Avi Kapoor

October 10, 2024 | 2:44 pm

Barclays analyst Tim Long has maintained an Overweight rating on American Tower (NYSE:AMT) and increased the price target from $223 to $255.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 2:14 pm

Analysts have provided 12 ratings for American Tower (NYSE:AMT) over the past three months, with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 6.4% to $239.58. American Tower's financial metrics, such as revenue growth and net margin, exceed industry averages, although its debt-to-equity ratio is higher, indicating financial risk.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 1:01 pm

Wells Fargo has downgraded American Tower (AMT) from Overweight to Equal-Weight and reduced its price target from $245 to $230.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:55 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.